Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial
Athena Philis‐Tsimikas, Marisse Asong, Edward Franek, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 6, pp. 414-425
Closed Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin
Julio Rosenstock, Stephen C. Bain, Amoolya Gowda, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 4, pp. 297-308
Open Access | Times Cited: 92
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
Chantal Mathieu, Björg Ásbjörnsdóttir, Harpreet S. Bajaj, et al.
The Lancet (2023) Vol. 401, Iss. 10392, pp. 1929-1940
Closed Access | Times Cited: 86
Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes
Ildiko Lingvay, Marisse Asong, Cyrus Desouza, et al.
JAMA (2023) Vol. 330, Iss. 3, pp. 228-228
Open Access | Times Cited: 82
Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5)
Harpreet S. Bajaj, Jens Aberle, Melanie J. Davies, et al.
Annals of Internal Medicine (2023) Vol. 176, Iss. 11, pp. 1476-1485
Closed Access | Times Cited: 50
The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa
Julio Rosenstock, Rattan Juneja, John M. Beals, et al.
Endocrine Reviews (2024) Vol. 45, Iss. 3, pp. 379-413
Open Access | Times Cited: 30
Robotic versus laparoscopic distal gastrectomy for resectable gastric cancer: a randomized phase 2 trial
Jun Lü, Binbin Xu, Hua‐Long Zheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Efficacy and safety of once‐weekly insulin icodec in type 2 diabetes: A meta‐analysis of ONWARDS phase 3 randomized controlled trials
Sahana Shetty, Renuka Suvarna
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 3, pp. 1069-1081
Open Access | Times Cited: 12
Continuous Glucose Monitoring–Based Metrics and Hypoglycemia Duration in Insulin-Experienced Individuals With Long-standing Type 2 Diabetes Switched From a Daily Basal Insulin to Once-Weekly Insulin Icodec: Post Hoc Analysis of ONWARDS 2 and ONWARDS 4
Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Lisbeth Carstensen, et al.
Diabetes Care (2024) Vol. 47, Iss. 4, pp. 729-738
Open Access | Times Cited: 10
Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes
Roberto Trevisan, Matteo Conti, Stefano Ciardullo
Diabetologia (2024) Vol. 67, Iss. 8, pp. 1480-1492
Open Access | Times Cited: 10
Current barriers to initiating insulin therapy in individuals with type 2 diabetes
Alba Galdón Sanz-Pastor, Alicia Justel Enríquez, Ana Sánchez Bao, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
Once-Weekly Insulin: A Breakthrough in Diabetes Management or an Unresolved Challenge?
Raheel Ahmed, Aimen Shafiq, Mushood Ahmed
British Journal of Hospital Medicine (2025), pp. 1-6
Closed Access | Times Cited: 1
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
Ildiko Lingvay, Malik Benamar, Liming Chen, et al.
Diabetologia (2025)
Open Access | Times Cited: 1
Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes
Thomas R. Pieber, Marisse Asong, Gabriele Fluhr, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 12, pp. 3716-3723
Open Access | Times Cited: 18
The Effect of Various Degrees of Renal or Hepatic Impairment on the Pharmacokinetic Properties of Once-Weekly Insulin Icodec
Hanne Haahr, Blanka Cieslarová, Janne R. Hingst, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 6, pp. 819-830
Open Access | Times Cited: 8
Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials
Harpreet S. Bajaj, Björg Ásbjörnsdóttir, Tanvir Johanning Bari, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 9, pp. 3810-3820
Open Access | Times Cited: 7
Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes
David Kerr, Jigar Rajpura, Tarlan Namvar
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 411-424
Open Access | Times Cited: 6
Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Peng Wang, Yu Zhang, W. Xu, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Understanding the Pharmacokinetics and Glucodynamics of Once Weekly Basal Insulins to Inform Dosing Principles: An Introduction to Clinicians
Thomas R. Pieber, Jennifer Leohr, Juliana Bue‐Valleskey, et al.
Endocrine Practice (2024) Vol. 30, Iss. 9, pp. 863-869
Open Access | Times Cited: 4
Insulin Icodec: First Approval
Hannah A. Blair
BioDrugs (2024) Vol. 38, Iss. 5, pp. 717-724
Closed Access | Times Cited: 4
Étude mixte sur l’intérêt et les freins relatifs à l’utilisation d’une insuline hebdomadaire chez les personnes vivant avec un diabète : étude INSUHEBDO
Arnaud Bubeck, Nicolas Naïditch, Coline Hehn, et al.
Médecine des Maladies Métaboliques (2025)
Closed Access
The rise of weekly insulins: addressing the challenges of type 2 diabetes care in Brazil
André Gustavo Daher Vianna, Diana Alves, Taís Silveira Assmann, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Perioperative and periprocedural management of once-weekly insulin treated patients
Robyn L. Houlden, Jeremy Gilbert, Tayyab Khan, et al.
Endocrine Practice (2025)
Closed Access
Once-Weekly Insulins
J. Hans DeVries, Tim Heise
Diabetes Technology & Therapeutics (2025)
Closed Access
Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the ONWARDS 1–5 trials
Peter Rossing, Malik Benamar, Alice Cheng, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Pharmacokinetic properties of once‐weekly insulin icodec in Chinese individuals with type 2 diabetes
Yijun Li, Ariel Fu, Shan Jiang, et al.
Journal of Diabetes Investigation (2025)
Open Access
Page 1 - Next Page

Scroll to top